Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma
To explore the clinical features and efficacy evaluation of large b-cell lymphoma in old age.
Diffuse Large B Cell Lymphoma
DRUG: (R)-CHOP regimen|DRUG: (R)-CVP regimen
Progression-free survival, Progression-free survival, up to end of follow-up-phase(approximately 24 months)
overall survival, overall survival, up to the date of death (approximately 5 years)|disease control rate, disease control rate, every 6 weeks,up to completion of treatment(approximately 18 weeks )]|objective remission rate, objective remission rate, every 6 weeks,up to completion of treatment(approximately 18 weeks )]
The results of the analysis of the treatment of large b-cell lymphoma in old age were analyzed, and the treatment of large B cell lymphoma was provided.